Sector Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.25 CHF | -1.01% |
|
+4.62% | - |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.29% | -0.99% | +3.48% | +15.68% | +3.83% | -1.20% | +10.66% | -18.55% | +205.97% | 47.74B | |
| -0.61% | +4.26% | +3.29% | +42.83% | +136.12% | +396.16% | +647.20% | +571.20% | - | 39.98B | |
| 0.00% | +4.93% | +16.44% | +9.03% | +7.27% | +11.81% | +55.56% | +21.04% | +1,090.28% | 36.23B | |
| +2.48% | +4.57% | +11.55% | +30.14% | -5.41% | +7.05% | -5.05% | -12.32% | +184.29% | 35.59B | |
| +0.62% | +3.53% | +7.72% | -8.02% | +3.67% | +5.41% | +42.19% | -17.51% | +149.07% | 27.91B | |
| -0.17% | +0.66% | -2.81% | +11.81% | - | - | - | - | - | 16.71B | |
| -2.00% | +11.64% | +11.82% | +39.87% | +4.94% | +31.71% | +136.81% | +244.38% | - | 16.45B | |
| +0.60% | -3.30% | -1.20% | +12.72% | +7.95% | +2.97% | +8.09% | -32.68% | +101.74% | 13.21B | |
| +1.82% | +1.56% | -0.64% | +63.53% | -7.38% | -9.75% | -30.15% | -24.54% | +116.69% | 12.93B | |
| +0.03% | -0.03% | +0.87% | +29.96% | +21.78% | +21.84% | -14.41% | -39.51% | +158.77% | 11.16B | |
| -2.21% | -5.79% | +32.89% | +15.86% | -8.06% | +94.21% | +530.41% | +256.52% | +2,542.00% | 11.1B | |
| 0.00% | +0.10% | +1.31% | +55.29% | +77.90% | +228.96% | +530.72% | - | - | 10.08B | |
| +0.62% | +4.00% | +47.30% | +32.19% | +36.37% | +29.23% | +49.92% | -53.23% | - | 9.54B | |
| -1.04% | +5.68% | -31.07% | -22.53% | -29.26% | +32.47% | +45.35% | +53.86% | +91.78% | 9.25B | |
| -0.47% | -0.91% | +1.79% | +26.96% | +41.43% | +140.34% | +396.62% | +89.28% | - | 9.05B | |
| -2.92% | +3.73% | -3.66% | -4.59% | +7.15% | +433.27% | +2,332.22% | +34.10% | - | 8.8B | |
| -0.30% | +1.95% | -4.27% | +56.33% | +88.46% | +101.80% | +74.14% | +118.43% | +1.83% | 8.79B | |
| -0.40% | +0.96% | +11.22% | +37.61% | +55.21% | +145.80% | +621.83% | +197.87% | - | 8.72B | |
| -0.70% | +1.48% | +4.24% | +7.85% | -13.22% | -24.65% | -21.21% | -28.79% | +53.49% | 8.5B | |
| Average | +0.13% | +1.52% | +5.80% | +23.82% | +23.82% | +91.52% | +300.61% | +79.97% | +426.90% | 17.99B | |
| Weighted average by Cap. | +0.74% | +2.19% | +6.66% | +22.65% | +26.12% | +86.96% | +225.68% | +98.70% | +423.62% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
